Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 11 publications
CD33 and clusterin interact biophysically and genetically to modulate Alzheimer risk.
Journal: Nature communications
Published: February 17, 2026
CD33 and clusterin interact biophysically and genetically to modulate Alzheimer risk.
Journal: Nature communications
Published: February 17, 2026
CD33 and clusterin interact biophysically and genetically to modulate Alzheimer risk.
Journal: bioRxiv : the preprint server for biology
Published: August 06, 2025
Amyloid-β toxicity modulates tau phosphorylation through the PAX6 signalling pathway.
Journal: Brain : a journal of neurology
Published: September 21, 2020
SORL1 mutations in early- and late-onset Alzheimer disease.
Journal: Neurology. Genetics
Published: June 13, 2016
Structural biology of presenilin 1 complexes.
Journal: Molecular neurodegeneration
Published: November 07, 2014
Structural interactions between inhibitor and substrate docking sites give insight into mechanisms of human PS1 complexes.
Journal: Structure (London, England : 1993)
Published: June 26, 2013
Interactome analyses of mature γ-secretase complexes reveal distinct molecular environments of presenilin (PS) paralogs and preferential binding of signal peptide peptidase to PS2.
Journal: The Journal of biological chemistry
Published: April 17, 2013
Vigilin interacts with signal peptide peptidase.
Journal: Proteome science
Published: January 16, 2012
ALS mutations in FUS cause neuronal dysfunction and death in Caenorhabditis elegans by a dominant gain-of-function mechanism.
Journal: Human molecular genetics
Published: September 28, 2011
Showing 1-11 of 11
Last Updated: 09/26/2026